These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26796281)
1. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma. Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281 [TBL] [Abstract][Full Text] [Related]
2. Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis. Xu HF; Chen L; Liu XD; Zhan YH; Zhang HH; Li Q; Wu B Asian Pac J Cancer Prev; 2014; 15(7):3045-50. PubMed ID: 24815445 [TBL] [Abstract][Full Text] [Related]
3. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells. Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088 [TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994 [TBL] [Abstract][Full Text] [Related]
5. Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression. Deng QJ; Xie LQ; Li H Life Sci; 2016 Jul; 157():38-44. PubMed ID: 27259812 [TBL] [Abstract][Full Text] [Related]
6. [The study on clinical significance of the expression of EGFL7 in laryngeal squamous cell carcinoma]. Gao S; Yang X; Li S; Tang Q Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(3):147-50. PubMed ID: 23700810 [TBL] [Abstract][Full Text] [Related]
7. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients. Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis. Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167 [TBL] [Abstract][Full Text] [Related]
9. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma. Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408 [TBL] [Abstract][Full Text] [Related]
10. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538 [TBL] [Abstract][Full Text] [Related]
11. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways. Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199 [TBL] [Abstract][Full Text] [Related]
13. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis. Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of epidermal growth factor-like domain-containing protein 7 is predictive of poor prognosis in patients with hepatocellular carcinoma. Yang C; Wang YL; Sun D; Zhu XL; Li Z; Ni CF J Cancer Res Ther; 2018; 14(4):867-872. PubMed ID: 29970668 [TBL] [Abstract][Full Text] [Related]
15. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma. Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361 [TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
17. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Wu F; Yang LY; Li YF; Ou DP; Chen DP; Fan C Hepatology; 2009 Dec; 50(6):1839-50. PubMed ID: 19824075 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer. Zhou L; Li J; Zhao YP; Guo JC; Cui QC; Zhou WX; Zhang TP; Wu WM; You L; Shu H Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):523-8. PubMed ID: 25308363 [TBL] [Abstract][Full Text] [Related]
19. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas. Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953 [TBL] [Abstract][Full Text] [Related]
20. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo. Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]